COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL studyThomas Chatzikonstantinou, Elżbieta Kalicińska, Anargyros Kapetanakis et al.|Leukemia|2021Cited by 94
The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>Andrea Visentin, Gilad Itchaki, Thomas Chatzikonstantinou et al.|American Journal of Hematology|2023Cited by 21
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of MyelofibrosisIrene Pastor‐Galán, Francisco Cervantes, Manuel Pérez‐Encinas et al.|Medicina Clínica (English Edition)|2020Cited by 12
Características clínico-biológicas de los pacientes con mielofibrosis: un análisis de 1.000 casos del Registro Español de MielofibrosisIrene Pastor‐Galán, Francisco Cervantes, Juan Carlos Hernández‐Boluda et al.|Medicina Clínica|2020Cited by 5